Verastem (VSTM) Change in Acquisitions & Divestments (2012 - 2024)
Verastem (VSTM) posted quarterly Change in Acquisitions & Divestments of $29.0 million for Q2 2024, up 107.14% year-over-year from $14.0 million in Q3 2023, and down 6.45% quarter-over-quarter from $31.0 million in Q1 2024.
Analysis
Verastem (VSTM) Change in Acquisitions & Divestments (2012 - 2024) Analysis & Trends
Verastem's Change in Acquisitions & Divestments history runs 13 years deep, the most recent figure standing at $29.0 million for Q2 2024.
- In Q2 2024, Change in Acquisitions & Divestments rose 107.14% year-over-year to $29.0 million; the TTM figure through Dec 2024 stood at $60.0 million (up 15.38% YoY), while the FY2024 annual figure was $60.0 million, up 15.38% from the prior year.
- Change in Acquisitions & Divestments for Q2 2024 stood at $29.0 million, down from $31.0 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $38.1 million in Q2 2021, with the low at $5.4 million in Q1 2021.
- The 5-year median for Change in Acquisitions & Divestments is $24.6 million (2022), against an average of $22.5 million.
- The sharpest annual moves came in 2021 and 2022: Change in Acquisitions & Divestments sank 83.23% in 2021, then soared 351.16% in 2022.
- Verastem's Change in Acquisitions & Divestments stood at $32.0 million in 2020, then gained by 3.74% to $33.2 million in 2021, then tumbled by 53.38% to $15.5 million in 2022, then soared by 61.29% to $25.0 million in 2023, then gained by 16.0% to $29.0 million in 2024.
- Business Quant data shows VSTM's Change in Acquisitions & Divestments at $29.0 million in Q2 2024, $31.0 million in Q1 2024, and $25.0 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 29.00 Mn |
| Mar 31, 2024 | 31.00 Mn |
| Dec 31, 2023 | 25.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 13.00 Mn |
| Dec 31, 2022 | 15.50 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 29.25 Mn |
| Mar 31, 2022 | 24.25 Mn |
| Dec 31, 2021 | 33.25 Mn |
| Sep 30, 2021 | 10.00 Mn |
| Jun 30, 2021 | 38.10 Mn |
| Mar 31, 2021 | 5.38 Mn |
| Mar 31, 2020 | 32.05 Mn |
| Dec 31, 2019 | 46.06 Mn |
| Sep 30, 2019 | 53.15 Mn |
| Jun 30, 2019 | 46.53 Mn |
| Mar 31, 2019 | 38.00 Mn |
| Dec 31, 2018 | 6.00 Mn |
| Mar 31, 2018 | 4.50 Mn |